Real-World Study on the Impact of Atopic Dermatitis From a Caregiver Perspective
NCT07323394 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-01-23
Summary
This study will address this gap by providing comprehensive data on disease burden from a caregiver perspective in a Canadian population, ultimately supporting improved clinical decision-making and healthcare resource allocation.
Conditions
- Atopic Dermatitis
- Eczema Atopic Dermatitis
- Eczema
- Caregiver
- Burden
Interventions
- OTHER
-
No Intervention: Observational Cohort
No specific intervention is assess in this study. Observational cohort.
Sponsors & Collaborators
-
PeriPharm
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-01-31
- Primary Completion
- 2026-06-30
- Completion
- 2026-07-31
More Related Trials
-
Results in Real Clinical Practice of Treatment of Moderate-severe Atopic Dermatitis
NCT05078294 ·Status: UNKNOWN
-
Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis
NCT07220577 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
NCT07003425 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)
NCT03569293 ·Status: COMPLETED ·Phase: PHASE3
-
Atopic Dermatitis Adherence Study
NCT02169986 ·Status: UNKNOWN ·Phase: NA
-
Evaluation and Comparison of 2 Cosmetic Investigational Products in Adults With Atopic Dermatitis
NCT03632174 ·Status: COMPLETED ·Phase: NA
-
A Study Evaluating APG777 in Atopic Dermatitis
NCT06395948 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants With Moderate-to-Severe Atopic Dermatitis
NCT06815380 ·Status: RECRUITING
-
Effects of Treatments on Atopic Dermatitis
NCT01631617 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
NCT04875169 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults
NCT01232985 ·Status: COMPLETED ·Phase: PHASE2
-
The Impact of Pediatric Skin Disorders: The "Big" Study
NCT03544866 ·Status: COMPLETED
-
Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials
NCT06174493 ·Status: NOT_YET_RECRUITING
-
A Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants of Atleast 12 Years Old Receiving Dupilumab Injections in Gulf Countries
NCT05214326 ·Status: COMPLETED
-
An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis
NCT05399368 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis
NCT03585296 ·Status: COMPLETED ·Phase: PHASE2
-
Finding Patterns In Clinical Trial Experiences of Patients With Eczema
NCT05747378 ·Status: NOT_YET_RECRUITING
-
A Psychoeducational Prevention for the Treatment of Atopic Dermatitis in Youth and Their Families
NCT02067234 ·Status: WITHDRAWN ·Phase: NA
-
Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
NCT03575871 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study of Canadian Patients (6 Years or Older) Receiving Dupixent® for Moderate to Severe Atopic Dermatitis
NCT06099704 ·Status: COMPLETED
-
Microbiome in Atopic Dermatitis Under Systemic Therapy
NCT05099315 ·Status: RECRUITING
-
Efficacy/Safety Study to Explore a New Revised Topical Formulation in Atopic Dermatitis
NCT01948869 ·Status: COMPLETED ·Phase: NA
-
Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma
NCT04927195 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Psychodermatologic Educational Modules on Atopic Dermatitis Patient Outcomes
NCT07009483 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of OC000459 on Moderate to Severe Atopic Dermatitis
NCT02002208 ·Status: COMPLETED ·Phase: PHASE2